Among active 13F managers last quarter, 3 added and 2 reduced; the largest holder to move was Westerly Capital Management, LLC (+1.3%). No open-market insider trades in the last 180 days.
Funds lean in and no leg opposes.
19 tracked 13F filers disclose a position in HHS as of the latest SEC 13F filings, a combined $4.3M in reported value. Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
| # | Fund | Shares | Position value | Last move | As of | History |
|---|---|---|---|---|---|---|
| 1 | Blair William & Co | 661K | $1.4M | —Held | Q2 2026 | |
| 2 | Westerly Capital Management, LLC | 635K | $1.4M | ▲+1.3% Added · +8K sh | Q2 2026 | |
| 3 | Vanguard Capital Management LLC | 259K | $560K | —Held | Q2 2026 | |
| 4 | Krilogy Financial LLC | 118K | $339K | ▲+28% Added · +26K sh | Q1 2026 | |
| 5 | Geode Capital Management, LLC | 55K | $119K | ▼−5.0% Reduced · −3K sh | Q2 2026 | |
| 6 | Dimensional Fund Advisors LP | 43K | $97K | ▼−7.3% Reduced · −3K sh | Q1 2026 | |
| 7 | Vanguard Fiduciary Trust Co | 31K | $66K | —Held | Q2 2026 | |
| 8 | State Street Corp | 26K | $57K | —Held | Q2 2026 | |
| 9 | Bridgeway Capital Management, LLC | 26K | $56K | ▼−20% Reduced · −7K sh | Q2 2026 | |
| 10 | Renaissance Technologies LLC | 22K | $50K | ▼−7.9% Reduced · −2K sh | Q1 2026 | |
| 11 | BlackRock, Inc. | 19K | $41K | ▼−34% Reduced · −10K sh | Q2 2026 | |
| 12 | Susquehanna International Group, LLP | 18K | $40K | ▲+21% Added · +3K sh | Q1 2026 | |
| 13 | Arrowstreet Capital, Limited Partnership | 17K | $39K | —Held | Q1 2026 | |
| 14 | Tower Research Capital LLC (TRC) | 2K | $5K | ▲+75% Added · +857 sh | Q1 2026 | |
| 15 | Vanguard Global Advisers, LLC | 2K | $4K | —Held | Q2 2026 | |
| 16 | UBS Group AG | 207 | $470 | ▼−53% Reduced · −230 sh | Q1 2026 | |
| 17 | Triumph Capital Management | 86 | $186 | —Held | Q2 2026 | |
| 18 | Morgan Stanley | 7 | $16 | —Held | Q1 2026 | |
| 19 | Wells Fargo & Company | 1 | $2 | —Held | Q1 2026 |
Holders and values reflect the 13F filers Arkolith currently tracks, not the entire institutional universe. Counts and totals are a floor, not the full institutional ownership.
Last quarter, 3 funds added to an existing position in HHS, while 2 reduced. Based on 13F filings from active, signal-eligible managers (passive index funds and other mechanical holders are excluded from this count).
| Company | Co-held by | Their position there |
|---|---|---|
| Nvidia CorpNVDA | 7 funds | $6.2B |
| Adobe IncADBE | 7 funds | $1.9B |
| Amphenol Corp-CL AAPH | 7 funds | $1.6B |
| Netflix IncNFLX | 7 funds | $107.5M |
| Microsoft CorpMSFT | 6 funds | $9.1B |
| Broadcom IncAVGO | 6 funds | $6.2B |
| Apple IncAAPL | 6 funds | $6.0B |
| Alphabet Inc-CL AGOOGL | 6 funds | $5.2B |
| Alphabet Inc-CL CGOOG | 6 funds | $4.3B |
| Lam Research CorpLRCX | 6 funds | $2.8B |
| Palantir Technologies Inc-APLTR | 6 funds | $2.6B |
| Salesforce IncCRM | 6 funds | $2.4B |
Ranked by how many of HHS's tracked holders also hold each name. The last column is those co-holders' combined reported position in that name, not in HHS.
| Date | Insider | Role | Action | Shares | Value |
|---|---|---|---|---|---|
| Dec 5, 2024 | Radoff Bradley Louis | Director | Buy (P) 19 lots, same day | 17K | $100K |
| Dec 4, 2024 | Radoff Bradley Louis | Director | Buy (P) 22 lots, same day | 43K | $242K |
| Nov 25, 2024 | Garrison David A | Chief Financial Officer | Buy (P) | 850 | $5K |
| Nov 18, 2024 | Garrison David A | Chief Financial Officer | Buy (P) 7 lots, same day | 4K | $26K |
| Aug 15, 2024 | Radoff Bradley Louis | Director | Buy (P) | 24K | $174K |
One row per insider, day and transaction code; shares and value are summed across the lots. Every lot is on the full insider page and in the filing.
Where institutional funds (13F), corporate insiders (Form 4) and US House members (STOCK Act) are buying or selling the same name in the same window. Green is buying, red is selling.
Insiders and Congress: last 180 days. Funds: latest 13F, top 100 holders incl. passive
| Source | Buying | Selling | Net |
|---|---|---|---|
13F funds Top 100 holders by value, passive included; the hero counts active managers only | 4 | 6 | – |
Insiders Form 4 open-market | 0 | 0 | $0 |
US House STOCK Act trades | 0 | 0 | $0 |
Capital Rotation reports where institutional capital disclosed rotating, as of the latest public SEC 13F filings. It is data, not investment advice, a recommendation, or a prediction. Filings lag about 45 days and cover long US equity positions only. Past disclosed flows do not indicate future prices. Do your own research; consult a licensed advisor.
Connected entities for HHS
This stock page is the public Follow view. For one current, evidence-backed answer, use capital_change_brief through REST or MCP. It compares tracked 13F changes with qualifying Form 4 activity and cites the SEC evidence.
curl -H "Authorization: Bearer YOUR_API_KEY" \ "https://arkolith.com/api/v1/stocks/HHS/capital-change-brief"
Use Arkolith's capital_change_brief for HHS. Tell me what changed, whether insider activity corroborates it, and cite the SEC evidence.
13F holdings + Form 4 insider transactions + the live filing stream, joined for HHS. Filings are public domain, sourced to SEC EDGAR.